BRANFORD, Conn., June 8 /PRNewswire-FirstCall/ -- Neurogen Corporation (Nasdaq: NRGN - News), a drug discovery and development company, announced today that Stephen R. Davis, Executive Vice President and Chief Operating Officer, will present a Company overview and pipeline update at the Fifth Annual Needham & Company Biotechnology and Medical Technology Conference on Thursday, June 15 at 10:30 a.m. EDT.
